| P50 | author | Thierry Poynard | Q43252014 |
| P2093 | author name string | Yves Benhamou | |
| P2860 | cites work | Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients | Q28375088 |
| | Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection | Q30492398 |
| | Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease | Q32086267 |
| | Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. | Q35905947 |
| | Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies | Q38176321 |
| | In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir). | Q38529394 |
| | Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus | Q39451785 |
| | Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir | Q40887887 |
| | Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine | Q41813040 |
| | Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus | Q42006642 |
| | Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. | Q42552411 |
| | Hepatitis B virus infection in the acquired immunodeficiency syndrome | Q43437141 |
| | Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study | Q43599844 |
| | Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation | Q43635554 |
| | Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). | Q43674732 |
| | YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient | Q43772654 |
| | Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections | Q43851688 |
| | Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV. | Q43863563 |
| | The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response | Q43993272 |
| | The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state | Q44068644 |
| | Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro | Q44820781 |
| | Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee | Q45741556 |
| | Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine | Q45747739 |
| | Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee | Q45747996 |
| | Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. | Q45750465 |
| | Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine | Q45768670 |
| | Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon | Q45834520 |
| | Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors | Q45843781 |
| | Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population | Q59306542 |
| | Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor | Q73217072 |
| | Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA) | Q73271744 |
| | Elevated liver enzymes following initiation of antiretroviral therapy | Q73801521 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| | chronic hepatitis B | Q55779876 |
| | chronic hepatitis | Q62019625 |
| P304 | page(s) | S194-9 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus | |
| P478 | volume | 39 Suppl 1 | |